Algorithm used for analysis of patient cases. Testing pipeline developed for downstream characterization of low-density array⁺ (LDA⁺) patient cases for identification of specific genetic events to allocate subgroups for specific targeted therapies with ABL-class TKIs and JAK inhibitors. CNS, central nervous system; HR, high risk; mut, mutation; QNS, quantity not sufficient; R, rearrangement; SR, standard risk.